• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌——有多少患者可能受益于前哨淋巴结清扫术?

Endometrial cancer-how many patients could benefit from sentinel lymph node dissection?

机构信息

Rotkreuzklinikum München, Frauenklinik Taxisstraße 3, 80637, München, Germany.

Pathologie Rotkreuzklinikum, Winthirstraße 11, 80639, München, Germany.

出版信息

World J Surg Oncol. 2018 May 17;16(1):95. doi: 10.1186/s12957-018-1392-8.

DOI:10.1186/s12957-018-1392-8
PMID:29773071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5956846/
Abstract

BACKGROUND

Sentinel lymph node dissection (SLND) may reduce morbidity in patients with endometrial cancer. The objective of this study is to estimate how many systematic lymph node dissections (LND) can be spared with an implementation of a SLN-procedure.

METHODS

Retrospective, single-center study, SLND according to NCCN-Guidelines.

RESULTS

In 109 patients of 154 consecutive patients, SLND was performed. The detection rate was 61% on both sides and 86% on at least one side. Classification of uterine risk factors is as follows: low risk 53, intermediate risk 25, high-intermediate risk 13, and high-risk 18. Stage IIIC: 0, 3, 7, 11, respectively. Under the assumption that 56 patients with "higher than low risk" factors would be treated by systematic LND, we spared 26 pelvic and paraaortic LND. After failures of SLN detection, unilateral pelvic LND was performed in 15 patients. Patients with "higher than low risk" factors and node-negative SLN are candidates for a randomized study to prove safety and efficacy. Only every third patient in our study met these criteria.

CONCLUSIONS

In a cohort of patients with "higher than low risk" endometrial cancer, the implementation of SLND nearly divided the number of radical lymph node dissections in half. Further studies are required to define the best modalities for SLND.

摘要

背景

前哨淋巴结清扫术 (SLND) 可能降低子宫内膜癌患者的发病率。本研究旨在评估实施 SLN 手术可以节省多少系统性淋巴结清扫术 (LND)。

方法

回顾性、单中心研究,根据 NCCN 指南进行 SLND。

结果

在 154 例连续患者中的 109 例患者中进行了 SLND。双侧检出率为 61%,至少一侧为 86%。子宫危险因素分类如下:低危 53 例,中危 25 例,中高危 13 例,高危 18 例。ⅡIC 期:分别为 0、3、7、11。假设 56 例“高危因素”患者接受系统性 LND 治疗,我们节省了 26 例盆腔和腹主动脉旁 LND。SLN 检测失败后,15 例患者行单侧盆腔 LND。具有“高危因素”和淋巴结阴性 SLN 的患者是随机研究安全性和疗效的候选者。在我们的研究中,只有每三个患者符合这些标准。

结论

在“高危因素”子宫内膜癌患者队列中,实施 SLND 可使根治性淋巴结清扫术的数量减少近一半。需要进一步研究以确定 SLND 的最佳方式。

相似文献

1
Endometrial cancer-how many patients could benefit from sentinel lymph node dissection?子宫内膜癌——有多少患者可能受益于前哨淋巴结清扫术?
World J Surg Oncol. 2018 May 17;16(1):95. doi: 10.1186/s12957-018-1392-8.
2
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.比较前哨淋巴结活检与淋巴结切除术用于子宫内膜癌分期的研究(FIRES 试验):一项多中心、前瞻性、队列研究。
Lancet Oncol. 2017 Mar;18(3):384-392. doi: 10.1016/S1470-2045(17)30068-2. Epub 2017 Feb 1.
3
Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.腹腔镜吲哚菁绿示踪子宫内膜癌前哨淋巴结图谱
Ann Surg Oncol. 2016 Jul;23(7):2206-11. doi: 10.1245/s10434-016-5090-x. Epub 2016 Jan 20.
4
The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.前哨淋巴结绘图在高危子宫内膜癌分期中的影响。
Ann Surg Oncol. 2017 Dec;24(13):3981-3987. doi: 10.1245/s10434-017-6132-8. Epub 2017 Oct 20.
5
Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.多中心研究比较了经前哨淋巴结算法评估淋巴结与全面盆腔和腹主动脉旁淋巴结切除术治疗浆液性和透明细胞子宫内膜癌患者的肿瘤学结局。
Gynecol Oncol. 2020 Jan;156(1):62-69. doi: 10.1016/j.ygyno.2019.11.002. Epub 2019 Nov 24.
6
Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer.仅脂肪的前哨淋巴结:在使用吲哚菁绿对子宫内膜癌患者进行前哨淋巴结绘图算法的适应性改变中发现的结果。
Int J Gynecol Cancer. 2019 Jan;29(1):53-59. doi: 10.1136/ijgc-2018-000008.
7
Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.使用荧光成像的两步法前哨淋巴结定位策略在子宫内膜癌分期中的应用:一种新型前哨淋巴结示踪剂注射程序。
Surg Oncol. 2018 Sep;27(3):514-519. doi: 10.1016/j.suronc.2018.07.001. Epub 2018 Jul 2.
8
Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).风险组能否准确预测前哨淋巴结阳性子宫内膜癌患者的非前哨淋巴结转移?一项土耳其妇科肿瘤学组研究(TRSGO-SLN-004)。
J Surg Oncol. 2021 Feb;123(2):638-645. doi: 10.1002/jso.26310. Epub 2020 Dec 1.
9
Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.前哨淋巴结定位算法与根治性淋巴结清扫术在检测具有较高淋巴结转移风险的IIIC期子宫内膜癌中的比较。
Gynecol Oncol. 2017 Dec;147(3):541-548. doi: 10.1016/j.ygyno.2017.09.030. Epub 2017 Sep 29.
10
Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.子宫内膜癌前哨淋巴结活检——可行性、安全性和淋巴并发症。
Gynecol Oncol. 2018 Mar;148(3):491-498. doi: 10.1016/j.ygyno.2017.12.017. Epub 2017 Dec 20.

引用本文的文献

1
Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer-A Multidisciplinary Exhaustive Approach to Nodal Staging.子宫内膜癌前哨淋巴结活检:双注射、双示踪剂——一种用于淋巴结分期的多学科全面方法
Cancers (Basel). 2022 Feb 13;14(4):929. doi: 10.3390/cancers14040929.
2
Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review.子宫内膜癌前哨淋巴结定位:综述
Front Oncol. 2021 Jun 29;11:701758. doi: 10.3389/fonc.2021.701758. eCollection 2021.
3
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.欧洲妇科肿瘤学会/欧洲放射肿瘤学会/西班牙妇科肿瘤学会子宫内膜癌患者管理指南
Virchows Arch. 2021 Feb;478(2):153-190. doi: 10.1007/s00428-020-03007-z.
4
Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.术前 18F-FDG PET/CT 肿瘤标志物预测原发性子宫内膜癌淋巴结转移的效能优于 MRI 标志物。
Eur Radiol. 2020 May;30(5):2443-2453. doi: 10.1007/s00330-019-06622-w. Epub 2020 Feb 7.
5
Sentinel Lymph Nodes in Endometrial Cancer Update 2018.子宫内膜癌前哨淋巴结:2018年更新
Gynecol Minim Invasive Ther. 2019 Aug 29;8(3):94-100. doi: 10.4103/GMIT.GMIT_130_18. eCollection 2019 Jul-Sep.

本文引用的文献

1
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.子宫内膜癌前哨淋巴结图谱绘制与分期:妇科肿瘤学会文献综述及共识推荐
Gynecol Oncol. 2017 Aug;146(2):405-415. doi: 10.1016/j.ygyno.2017.05.027. Epub 2017 May 28.
2
The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.术前正电子发射断层扫描/计算机断层扫描在磁共振成像阴性淋巴结子宫内膜癌中的价值。
Ann Surg Oncol. 2017 Aug;24(8):2303-2310. doi: 10.1245/s10434-017-5901-8. Epub 2017 May 26.
3
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.比较前哨淋巴结活检与淋巴结切除术用于子宫内膜癌分期的研究(FIRES 试验):一项多中心、前瞻性、队列研究。
Lancet Oncol. 2017 Mar;18(3):384-392. doi: 10.1016/S1470-2045(17)30068-2. Epub 2017 Feb 1.
4
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.ProMisE验证:一种简单的、基于基因组学的子宫内膜癌临床分类器。
Cancer. 2017 Mar 1;123(5):802-813. doi: 10.1002/cncr.30496. Epub 2017 Jan 6.
5
Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.ESMO/ESGO/ESTRO 中高风险子宫内膜癌女性患者手术淋巴结分期的呼吁:来自FRANCOGYN研究组的多中心队列分析
Ann Surg Oncol. 2017 Jun;24(6):1660-1666. doi: 10.1245/s10434-016-5731-0. Epub 2017 Jan 5.
6
Axillary treatment for operable primary breast cancer.可手术原发性乳腺癌的腋窝治疗
Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD004561. doi: 10.1002/14651858.CD004561.pub3.
7
Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.子宫内膜癌前哨淋巴结评估:一项系统综述与荟萃分析
Am J Obstet Gynecol. 2017 May;216(5):459-476.e10. doi: 10.1016/j.ajog.2016.11.1033. Epub 2016 Nov 18.
8
Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99 with blue dye versus indocyanine green fluorescent dye.I期子宫内膜癌患者前哨淋巴结定位:通过比较放射性示踪剂Tc99与蓝色染料及吲哚菁绿荧光染料进行双侧定位识别的研究重点
J Cancer Res Clin Oncol. 2017 Mar;143(3):475-480. doi: 10.1007/s00432-016-2297-y. Epub 2016 Nov 3.
9
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.前哨淋巴结活检阳性黑色素瘤患者完全淋巴结清扫与不清扫(DeCOG-SLT):一项多中心、随机、III 期临床试验。
Lancet Oncol. 2016 Jun;17(6):757-767. doi: 10.1016/S1470-2045(16)00141-8. Epub 2016 May 5.
10
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery.肥胖对接受机器人手术的新诊断子宫癌患者前哨淋巴结定位的影响。
Ann Surg Oncol. 2016 Aug;23(8):2522-8. doi: 10.1245/s10434-016-5134-2. Epub 2016 Feb 23.